HTLV-1/

Nicolas Tardiota1, Noushin Jaberolansar1,2, Julia A Lackenby1,2

  • 1The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia.

Virology journal
|January 10, 2024
PubMed
概括

这项研究模拟了人类T淋巴细胞病毒1型 (HTLV-1) 逆转录酶. 核酸抑制剂对HTLV-1治疗有前途,支持现有抗病毒药物的临床试验.